ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 161 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2018. The put-call ratio across all filers is 3.67 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $18,423,000 | +221.5% | 254,704 | +192.7% | 0.37% | +243.1% |
| Q4 2017 | $5,730,000 | +119.9% | 87,029 | +67.4% | 0.11% | +147.7% |
| Q3 2017 | $2,606,000 | -86.2% | 51,997 | -95.3% | 0.04% | -73.8% |
| Q1 2016 | $18,863,000 | -19.6% | 1,115,467 | +5.8% | 0.17% | -10.6% |
| Q4 2015 | $23,472,000 | +34.7% | 1,054,452 | +42.7% | 0.19% | +31.5% |
| Q3 2015 | $17,431,000 | -60.6% | 738,911 | +36.6% | 0.14% | -54.3% |
| Q2 2015 | $44,241,000 | +93.3% | 541,114 | +118.9% | 0.31% | +100.6% |
| Q1 2015 | $22,890,000 | +9129.8% | 247,195 | +3930.6% | 0.16% | +7700.0% |
| Q4 2014 | $248,000 | – | 6,133 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |